Most patients (93%) had a duration of response of at least 12 months at the 1.75mg/kg dose of zilo-V, which is what will be tested in the new phase 3 trial, whose primary endpoint will be ...

On Jan. 27, Judge Liman set a trial date in the matter of Lively and ... Lively's attorneys cited California Civil Code section 47.1, a law designed to protect people who report allegations ...